MoonLake
Andrew Fox is currently serving as the Vice President of Regulatory Affairs at MoonLake Immunotherapeutics. Prior to his current role, he held various leadership positions in regulatory affairs at companies such as Akamis, Kinesys Consulting Ltd, STEPSTONE Pharma GmbH, AstraZeneca, Exelixis, Onyx Pharmaceuticals, Amgen, Warner Lambert/Parke Davis, and Sanofi Pasteur MSD. Andrew also has a BSc in Biological Science from the University of Birmingham. His vast experience and expertise in regulatory affairs have made him a valuable asset in the pharmaceutical industry.
This person is not in any offices
MoonLake
2 followers
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.